UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Establishment of human tumor xenografts in immunodeficient mice

Nature protocols, 2007-02, Vol.2 (1), p.247-250

2007

Volltextzugriff (PDF)

Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft models

Scientific reports, 2024-08, Vol.14 (1), p.19891-13, Article 19891

2024

Volltextzugriff (PDF)

The role of histone demethylase KDM4B in Myc signaling in neuroblastoma

JNCI : Journal of the National Cancer Institute, 2015-06, Vol.107 (6), p.djv080-djv080

2015

Volltextzugriff (PDF)

Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor

Nature communications, 2019-12, Vol.10 (1), p.5806-13, Article 5806

2019

Volltextzugriff (PDF)

Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)

Pediatric blood & cancer, 2010-07, Vol.55 (1), p.26-34

2010

Volltextzugriff (PDF)

Regulated lysosomal exocytosis mediates cancer progression

Science advances, 2015-12, Vol.1 (11), p.e1500603-e1500603

2015

Volltextzugriff (PDF)

The pediatric preclinical testing program: Description of models and early testing results

Pediatric blood & cancer, 2007-12, Vol.49 (7), p.928-940

2007

Volltextzugriff (PDF)

Multisite Promiscuity in the Processing of Endogenous Substrates by Human Carboxylesterase 1

Journal of molecular biology, 2006-10, Vol.363 (1), p.201-214

2006

Volltextzugriff (PDF)

Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the pediatric preclinical testing program

Pediatric blood & cancer, 2010-07, Vol.54 (7), p.921-926

2010

Volltextzugriff (PDF)

Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program

Pediatric Blood & Cancer, 2008-06, Vol.50 (6), p.1190-1197

2008

Volltextzugriff (PDF)

Preventing packaging of translatable P5-associated DNA contaminants in recombinant AAV vector preps

Molecular therapy. Methods & clinical development, 2022-03, Vol.24, p.280-291

2022

Volltextzugriff (PDF)

Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity

PloS one, 2013-02, Vol.8 (2), p.e51309-e51309

2013

Volltextzugriff (PDF)

Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program

Molecular cancer therapeutics, 2010-01, Vol.9 (1), p.101-112

2010

Volltextzugriff (PDF)

Molecular Characterization of the Pediatric Preclinical Testing Panel

Clinical cancer research, 2008-07, Vol.14 (14), p.4572-4583

2008

Volltextzugriff (PDF)

Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme

Nature structural & molecular biology, 2003-05, Vol.10 (5), p.349-356

2003

Volltextzugriff (PDF)

Initial testing (stage 1) of AZD6244 (ARRY-142886) by the pediatric preclinical testing program

Pediatric blood & cancer, 2010-10, Vol.55 (4), p.668-677

2010

Volltextzugriff (PDF)

Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program

Pediatric blood & cancer, 2010-08, Vol.55 (2), p.295-303

2010

Volltextzugriff (PDF)

Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1

Journal of interferon & cytokine research, 2012-08, Vol.32 (8), p.368-377

2012

Volltextzugriff (PDF)

Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin

Communications biology, 2024-04, Vol.7 (1), p.426-426, Article 426

2024

Volltextzugriff (PDF)

Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program

Pediatric blood & cancer, 2011-04, Vol.56 (4), p.595-603

2011

Volltextzugriff (PDF)

Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program

Pediatric blood & cancer, 2014-02, Vol.61 (2), p.245-252

2014

Volltextzugriff (PDF)

Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program

Pediatric blood & cancer, 2008-01, Vol.50 (1), p.37-45

2008

Volltextzugriff (PDF)

SK-NEP-1 and Rh1 are Ewing family tumor lines

Pediatric blood & cancer, 2008-03, Vol.50 (3), p.703-706

2008

Volltextzugriff (PDF)

Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program

Pediatric blood & cancer, 2012-06, Vol.58 (6), p.916-923

2012

Volltextzugriff (PDF)

1 – 25 von 482

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(441)
Mit Volltextzugriff
(418)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Establishment of human tumor xenografts in immunodeficient mice

Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant

Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft models

The role of histone demethylase KDM4B in Myc signaling in neuroblastoma

Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor

Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)

Regulated lysosomal exocytosis mediates cancer progression

The pediatric preclinical testing program: Description of models and early testing results

Multisite Promiscuity in the Processing of Endogenous Substrates by Human Carboxylesterase 1

Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the pediatric preclinical testing program

Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program

Preventing packaging of translatable P5-associated DNA contaminants in recombinant AAV vector preps

Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity

Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program

Molecular Characterization of the Pediatric Preclinical Testing Panel

Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme

Initial testing (stage 1) of AZD6244 (ARRY-142886) by the pediatric preclinical testing program

Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program

Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1

Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin

Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program

Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program

Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program

SK-NEP-1 and Rh1 are Ewing family tumor lines

Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program

Suchergebnisse filtern